Physiologically‐based pharmacokinetics modeling to investigate formulation factors influencing the generic substitution of dabigatran etexilate
Abstract The exposure‐response relationship of direct acting oral anti‐coagulants (DOACs) for bleeding risk is steep relative to ischemic stroke reduction. As a result, small changes in exposure may lead to bleeding events. The overall goal of this project was to determine the effect of critical for...
Main Authors: | Nashid Farhan, Rodrigo Cristofoletti, Sumit Basu, Sarah Kim, Karthik Lingineni, Sibo Jiang, Joshua D. Brown, Lanyan (Lucy) Fang, Lawrence J. Lesko, Stephan Schmidt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-03-01
|
Series: | CPT: Pharmacometrics & Systems Pharmacology |
Online Access: | https://doi.org/10.1002/psp4.12589 |
Similar Items
-
Dabigatran etexilate tetrahydrate
by: Hong-Qiang Liu, et al.
Published: (2012-12-01) -
The Discovery of Dabigatran Etexilate
by: Joanne evan Ryn, et al.
Published: (2013-02-01) -
Dabigatran etexilate: a direct thrombin inhibitor
by: M. Dugnani
Published: (2013-05-01) -
New options with dabigatran etexilate in anticoagulant therapy
by: Lars Maegdefessel, et al.
Published: (2010-05-01) -
Dabigatran Etexilate: A Review in Pediatric Venous Thromboembolism
by: Paik, J.
Published: (2022)